Literature DB >> 10421196

Triolein-induced pulmonary embolization and increased microvascular permeability in isolated perfused rat lungs.

Y Nakata1, H Tanaka, Y Kuwagata, T Yoshioka, H Sugimoto.   

Abstract

BACKGROUND: The pathophysiologic mechanism of the fat embolism syndrome is poorly understood. This study was designed to determine the effects of fat emboli on pulmonary vasculature.
METHOD: Triolein was infused into isolated rat lungs perfused with Krebs-Henseleit buffer. Pulmonary arterial pressure and microvascular permeability (Kf) were measured at baseline and 20 minutes after the triolein infusion. RESULT: The 99% triolein produced dose-dependent increases in both pulmonary arterial pressure and Kf. The 65% triolein, containing free fatty acid, resulted in a greater increase in Kf. Pretreatment with indomethacin attenuated the increase in Kf after 65% triolein but not after 99% triolein.
CONCLUSION: Pure triolein induced mainly embolization in the pulmonary vasculature, and 65% triolein caused embolization and subsequently increased vascular permeability, which are, at least in part, mediated by the action of cyclooxygenase products. Free fatty acids might induce permeability edema by means of a cyclooxygenase-dependent mechanism. We conclude that triolein-induced increases in pulmonary arterial pressure and Kf in isolated rat lungs provides a useful model of acute lung injury by fat embolism.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10421196     DOI: 10.1097/00005373-199907000-00024

Source DB:  PubMed          Journal:  J Trauma        ISSN: 0022-5282


  9 in total

1.  Acute lung injury in a bodybuilder.

Authors:  Jacques Abi Rached; Sanaa Rizk; Badiaa El-Imad; Abdallah Geara
Journal:  Intern Emerg Med       Date:  2010-04-21       Impact factor: 3.397

2.  Blood-brain barrier experiments with clinical magnetic resonance imaging and an immunohistochemical study.

Authors:  Jun Woo Park; Hak Jin Kim; Geun Sung Song; Hyung Soo Han
Journal:  J Korean Neurosurg Soc       Date:  2010-03-31

3.  The renin inhibitor aliskiren protects rat lungs from the histopathologic effects of fat embolism.

Authors:  Amanda N Fletcher; Agostino Molteni; Rakesh Ponnapureddy; Chirag Patel; Mark Pluym; Alan M Poisner
Journal:  J Trauma Acute Care Surg       Date:  2017-02       Impact factor: 3.313

4.  Experimental cerebral fat embolism: embolic effects of triolein and oleic acid depicted by MR imaging and electron microscopy.

Authors:  Hak Jin Kim; Jong Hwa Lee; Chang Hun Lee; Suk Hong Lee; Tae Yong Moon; Byung Mann Cho; Hae Kyu Kim; Byung Rae Park; Kee Hyun Chang
Journal:  AJNR Am J Neuroradiol       Date:  2002-10       Impact factor: 3.825

5.  Hemorrhage in cerebral fat embolisms in a cat model using triolein dependent on the physical properties of triolein.

Authors:  Yong-Woo Kim; Hak J Kim; Seon H Choi; Byungmann Cho; Lee Hwangbo; Dong C Kim
Journal:  Jpn J Radiol       Date:  2013-11-28       Impact factor: 2.374

6.  Experimental pulmonary fat embolism: computed tomography and pathologic findings of the sequential changes.

Authors:  Ok Hee Woo; Hwan Seok Yong; Yu-Whan Oh; Bong Kyung Shin; Han Kyeom Kim; Eun-Young Kang
Journal:  J Korean Med Sci       Date:  2008-08       Impact factor: 2.153

7.  MR imaging of the brain in fat embolism syndrome.

Authors:  Joseph Jen-Sho Chen; James C Ha; Stuart E Mirvis
Journal:  Emerg Radiol       Date:  2007-10-13

8.  Intra-arterial delivery of triolein emulsion increases vascular permeability in skeletal muscles of rabbits.

Authors:  Hak Jin Kim; Yong Woo Kim; In Sook Lee; Jong Woon Song; Yeon Joo Jeong; Seon Hee Choi; Kyung Un Choi; Kuen Tak Suh; Byung Mann Cho
Journal:  Acta Vet Scand       Date:  2009-07-16       Impact factor: 1.695

9.  Cardiorespiratory effects of venous lipid micro embolization in an experimental model of mediastinal shed blood reinfusion.

Authors:  Atli Eyjolfsson; Ignacio Plaza; Björn Brondén; Per Johnsson; Magnus Dencker; Henrik Bjursten
Journal:  J Cardiothorac Surg       Date:  2009-09-15       Impact factor: 1.637

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.